Efficacy of PSMA PET-Guided Radiotherapy for Oligometastatic Castrate-Resistant Prostate Cancer.

Henkenberens, Christoph; Derlin, Thorsten; Bengel, Frank; Ross, Tobias L; Kuczyk, Markus A; Giordano, Frank A; Sarria, Gustavo R; Schmeel, Leonard Christopher; Christiansen, Hans; von Klot, Christoph A J

Henkenberens, Christoph; Derlin, Thorsten; Bengel, Frank; Ross, Tobias L; Kuczyk, Markus A; Giordano, Frank A; Sarria, Gustavo R; Schmeel, Leonard Christopher; Christiansen, Hans; von Klot, Christoph A J.

Afiliação

Henkenberens C; Department of Radiotherapy and Special Oncology, Hannover Medical School, Hannover, Germany.
Derlin T; Department of Radiation Oncology, University Hospital Bonn, Bonn, Germany.
Bengel F; Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany.
Ross TL; Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany.
Kuczyk MA; Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany.
Giordano FA; Department of Urology and Urologic Oncology, Hannover Medical School, Hannover, Germany.
Sarria GR; Department of Radiation Oncology, University Hospital Bonn, Bonn, Germany.
Schmeel LC; Department of Radiation Oncology, University Hospital Bonn, Bonn, Germany.
Christiansen H; Department of Radiation Oncology, University Hospital Bonn, Bonn, Germany.
von Klot CAJ; Department of Radiotherapy and Special Oncology, Hannover Medical School, Hannover, Germany.

Front Oncol ; 11: 664225, 2021.

Article em En | MEDLINE | ID: mdl-33954116

Palavras-chave

PSMA; castrate-resistant; metastasis-directed therapy; oligometastases; radiotherapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Prostata / Tratamento / Radioterapia Base de dados: MEDLINE Idioma: En Revista: Front Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google